Background. Chronic schistosome infections are associated with T-cell hyporesponsiveness and a strong regulatory network. Murine studies have shown that schistosome infections can induce regulatory CD1d hi B cells, which inhibit inflammatory responses. Here, we evaluated the influence of regulatory B cells (Bregs) on T-cell cytokines in vitro in human schistosomiasis.
Methods. Gabonese young adults were recruited from areas where Schistosoma haematobium (S.h) infections were high or low endemic. The study participants were categorized as infected or uninfected from an high endemic area or uninfected from a low endemic (nonendemic) area. Their B cells were studied for Breg subset markers and cocultured with allogenic anti-CD3-stimulated CD4 + T cells, followed by T-cell cytokine analysis. Results. A greater percentage of B cells from S. haematobium-infected donors expressed cytoplasmic interleukin 10 (IL-10) and membrane-bound latency-associated peptide/transforming growth factor β1, compared with uninfected donors. T cells produced less interferon γ, interleukin 4, and interleukin 17 upon coculture with B cells from schistosome-infected individuals only, while the conversion to CD25
hi FoxP3 + and the percentage of IL-10 + T cells was enhanced. Interestingly, depletion of the prominent IL-10-producing B-cell subset, CD1d hi cells, resulted in less IL-10 + T cells in the S. haematobium-infected group, while levels of FoxP3 + regulatory T cells remained unaffected. Conclusions. Schistosomes can induce functional Bregs in humans that may be instrumental in general T-cell hyporesponsiveness and may contribute to the increased regulatory milieu found in schistosomiasis.
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Helminths such as schistosomes are master regulators of host immune responses, characterized by polarized T-helper type 2 cells [1, 2] and a general T-cell hyporesponsiveness in the chronic stage of infection [3] . This is facilitated by a number of potent regulatory cell types and increased levels of immunosuppressive cytokines, such as interleukin 10 (IL-10) and/or transforming growth factor β (TGF-β) [4] [5] [6] . While B lymphocytes possess a variety of immune functions, more recently they were shown to be a relevant source of IL-10 and/ or TGF-β [7, 8] . Such B cells were termed regulatory B cells (Bregs) because they were able to ameliorate various hyperinflammatory diseases [9] [10] [11] [12] [13] . For example, IL-10-producing B cells suppressed experimental autoimmune encephalomyelitis, collagen-induced arthritis, and inflammatory bowel disease [14] [15] [16] [17] . Furthermore, TGF-β-producing B cells protected against acute allergic airway inflammation [8] and inhibited spontaneous T-helper type 1 (Th1) autoimmunity in nonobese diabetic mice [18] . Recently, Bregs have been considered relevant in infectious diseases, such as helminth infections. During Schistosoma mansoni infection, active Bregs were enriched in the splenic marginal zone and suppressed allergic responses via elevated IL-10 production and/or FoxP3 + T-regulatory cell (Treg) induction [19, 20] . Likewise, during chronic Heligmosomoides polygyrus infections, CD5 − CD23 hi B cells from mesenteric lymph nodes also reduced allergic airway inflammation, but they did so independently of IL-10 [21] .
Although the majority of studies on Bregs were conducted in mouse models, Bregs are now also known to be present in humans during infectious diseases. For example, during chronic hepatitis B virus infection, IL-10-producing CD24 hi CD38
hi B cells suppressed antigen-specific CD8 + T-cell responses [22] , while in systemic lupus erythematosus, IL-10 production by this Breg subset was impaired compared with findings in healthy controls, and as a consequence Th1 cytokine production was not reduced [23] . [26] . Although active TGF-β-producing CD5 + Bregs were described in healthy individuals in response to milk antigens [7] , the role of human TGF-β-expressing Bregs in infectious diseases has not yet been addressed. Enhanced numbers of IL-10-producing CD1d hi B cells were first described in helminth-infected Argentine patients with multiple sclerosis and could inhibit autoreactive T-cell responses in vitro [27] . We found a similarly elevated percentage of IL-10-producing B cells in Schistosoma haematobium-infected Gabonese children, which returned to baseline levels after antischistosome treatment [20] . However, the functional properties of these cells were not explored. In the current study, we investigated the regulatory characteristics of peripheral B cells from S. haematobium-infected individuals and the functional consequences for CD4 + T-cell activation. We observed that CD1d 
MATERIALS AND METHODS

Study Population
Heparinized venous blood was obtained from S. haematobiumuninfected young adults living in Lambaréné, Gabon, a semiurban municipality where S. haematobium is not endemic and the prevalence of S. haematobium infection is low; these individuals composed the "nonendemic uninfected group." Infected donors and additional uninfected donors were recruited from the rural village Bindo, where S. haematobium is endemic, residents are likely to have a history of S. haematobium infections, and no intervention studies have been performed [28] ; these donor groups composed the "endemic infected group" and the "endemic uninfected group," respectively. Current users of praziquantel were excluded from study participation, as were people who had lived in either region for <1 year before enrollment. The presence of helminth and protozoan infections was determined as previously reported [20] (Table 1) . Infections with Plasmodium falciparum and Plasmodium malariae were determined by polymerase chain reaction [29] , and infections with Loa loa and Mansonella perstans microfilariae were determined by microscopy [30] . Written informed consent was obtained from all participants, and they were treated according to local guidelines. The study was approved by the Comité d'Ethique Regional Independent de Lambaréné (CERIL N°08/10) and conducted according to the principles expressed in the Declaration of Helsinki.
Cell Isolation and Characterization
Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Hypaque density gradient centrifugation from approximately 40 In PBMCs, B cells were characterized using CD1d-PE, CD19-PacificBlue, and CD27-APCeFluor780 (all from eBioscience), CD24-PeCy7 (ITK), and CD38-FITC (BD). PFA-fixed PBMCs were characterized using CD1d-PE and CD20-APCeFluor780 (both from eBioscience), CD24-PeCy7 and CD27-Biotin (both from eBioscience) plus streptavidin-Qdot525 (Life Technologies), CD38-Horizon450 (BD), and LAP1-APC (Biolegend). For all flow cytometric measurements, FcγR-binding inhibitor was added, and fluorescence minus one values were used for gate setting for all surface markers and cytokines.
B-Cell Stimulation and Intracellular Staining
Freshly isolated B cells (1 × 10 5 ) were stimulated with 100 ng/ mL PMA, 1 µg/mL ionomycin, 10 µg/mL brefeldinA (all Sigma-Aldrich), and 10 µg/mL ultrapure lipopolysaccharide (LPS; Life Technologies) [25] . After 5 hours, the cells were fixated with 1.9% PFA (Sigma-Aldrich) and stained for CD1d-PE, CD20-APCeFluor780, CD24-PeCy7, CD27-APC (BD), CD38-FITC, IL-10-Biotin (Abd Serotec) plus streptavidin-Qdot525, and TNF-α-eFluor450 (eBioscience). were restimulated with PIB, fixed with PFA, and stained in 0.5% saponin buffer for IL-4-PE (BD), IL-10-Biotin plus streptavidin-Qdot525, and IL-17-FITC (all from Biolegend), IFN-γ-HorizonV450 (BD), TNF-α-PeCy7 (eBioscience), CD3-PerCPCy5.5 (BD), and CD20-APCeFluor780. After 6 days, restimulated cells fixed with eBioscience FoxP3 fixation buffer were stained in permeabilization buffer for CD1d-APC (Biolegend), CD3-PerCPeFluor710 (eBiosience), CD20-APCeFluor780 and CD25-PE (both from BD), IL-10-Biotin plus streptavidin-Qdot525, TNF-α-PeCy7, and FoxP3-eFluor450 (all from eBioscience), and Helios-FITC (Biolegend).
Functional In Vitro Assays
Statistical Analysis
For nonparametric analysis, Kruskal-Wallis, Mann-Whitney U, and Wilcoxon matched pairs tests were used. For categorical data, the Pearson χ 2 and Fisher exact tests was used. All tests were performed used GraphPad Prism. Correlations were Data are no. (%) of participants or mean value (range). The study was initiated in January 2011, and participants were from 2 villages in Gabon.
Abbreviation: PCR, polymerase chain reaction. a By the Kruskal-Wallis test for age. The Mann-Whitney test showed the following differences: P = .002 between the endemic infected and endemic uninfected group, P = .006 between the endemic infected and nonendemic uninfected groups, and P = .255 between the endemic uninfected and nonendemic uninfected groups. b By the Pearson χ 2 test. Because of sample size, the Fisher exact test was performed between the groups, and results showed no differences between the groups for all coinfections.
analyzed using SPSS Statistics 20 (IBM). A P value of <.05 was considered statistically significant.
RESULTS
Elevated B-Cell IL-10 and LAP/TGF-β1 Expression in S. haematobium-Infected Subjects
Peripheral blood specimens were collected from 14 young adults in the endemic infected group and compared to specimens from 12 individuals in the endemic uninfected group and from 12 individuals in the nonendemic uninfected group. As described in Table 1 , no significant differences were found between the 3 groups in the prevalence and intensity of other parasitic infections, such as malaria, Ascaris lumbricoides infection, Trichuris trichiura infection, or hookworm infection. Furthermore, sex was equally distributed, but the age of the S. haematobium-infected individuals was slightly lower than that of uninfected individuals. Age was not regarded as a confounder, however, as the real age differences were very small (3-4 years). The average number of isolated PBMCs (1.1× 10 6 , 1.0× 10 6 , and 1.0 × 10 6 cells/mL; P = .5) and the average percentage of isolated B cells (8.3%, 8.3%, and 6.2%; P = .4) were comparable between the endemic infected group, endemic uninfected group, and nonendemic uninfected group, respectively. CD19 + B cells isolated from peripheral blood specimens were studied for the presence of IL-10-competent B cells by a short, 5-hour stimulation period with PMA, ionomycin, brefeldin A, and LPS (PIB + LPS) as described by Iwata et al [25] . TNF-α was included as an inflammatory control. The percentage of CD19 + B cells expressing cytoplasmic IL-10 was highest in the endemic infected group and lowest in the nonendemic uninfected group (Figure 1 A) . TNF-α production was similar in all groups ( Figure 1A and Supplementary Figure 1A) . The percentage of IL-10-producing B cells was not correlated with age, helminth burden (based on S. haematobium egg counts; data not shown), or Plasmodium parasites ( Figure 1C ) [31] . Of note, PIB-only stimulation also showed a greater percentage IL-10-producing CD19 + B cells in the endemic infected group, compared with the other 2 groups, although in each group, levels after PIB-only stimulation were lower than those after PIB + LPS stimulation (data not shown).
We also analyzed the expression of LAP/TGF-β. Dissociation of this complex results in bioactive TGF-β1. B cells from the endemic infected group expressed significantly more LAP, while B cells from the endemic uninfected group showed an increased trend, compared with the nonendemic uninfected group ( Figure 1B and Supplementary Figure 1B) . We did not study the coexpression of TGF-β1 and IL-10 in B cells because this investigation requires different methods (ie, B cells need to be stimulated for IL-10, but not for LAP/TGF-B detection). These results indicate that schistosome infection or exposure induces elevated numbers of circulating IL-10-producing and/or LAP/TGF-β1-expressing B cells.
Phenotypic Characterization of IL-10-and LAP/TGF-β1-Expressing B Cells
To determine which Breg subset was responsible for the increased IL-10 production and/or LAP/TGF-β1 expression, PBMCs were analyzed for the presence of 3 different human PFA-fixed peripheral blood mononuclear cells were stained for latency-associated peptide (LAP)/transforming growth factor β1. The geometric mean fluorescence intensity (MFI) of LAP expression on total B cells was determined. C, Intracellular IL-10 in B cells after 5 hours of PIB + LPS stimulation. Donors were grouped according to the presence of malaria parasite infection (Mal) and/or S. haematobium infection. The malaria-negative S. haematobium-negative group contains 14 individuals (5 of whom were from Bindo), the malaria-positive S. haematobium-negative group contains 10 (7 of whom were from Bindo), the malaria-negative S. haematobiumpositive group contains 10, and the malaria-positive S. haematobiumpositive group contains 4. Donors from Bindo are depicted in Figure 1C as half-shadowed circles or squares and donor from Lambaréné as open circles or squares. Each individual is represented as a separate dot, with a line showing the median value for the group. Data were analyzed using the Mann-Whitney U test. Figure 2A and 2B and Supplementary Figure 1C) . Interestingly, in the endemic infected group, the subset with the greatest frequency of cells producing IL-10 was the CD1d hi B cell subset (25%), and only a small 
Schistosome-Induced B Cells Dampen the Proinflammatory T-Cell Cytokine Profile
We next performed in vitro CD4 + T and B-cell co-cultures in the presence of anti-CD3 to investigate whether the T-cell stimulatory activity of B cells from the endemic infected group is altered. Allogenic CD4 + T cells from a single donor were used, to prevent differences due to variation in T-cell donors. After 3 days, the cells were restimulated with PIB, and we observed slight but significantly lower percentages of CD4 + T cells producing IFN-γ, IL-4, and IL-17 when stimulated in the presence of B cells from the endemic infected group, compared with the nonendemic uninfected group, whereas TNF-α production was not affected (Figure 3A-D) . T cells stimulated with anti-CD3 only, in the absence of B cells, showed a variable degree of viability and were therefore excluded from the analysis. No significant differences were detected between endemic infected and endemic uninfected individuals, suggesting that past exposure to Schistosoma infections can yield changes in B-cell function, reflected in the slightly enhanced IL-10 and TGF-β expression (Figure 2 ), which may be sufficient to control effector T-cell responses. percentage of T cells expressing IL-10 returned to levels similar to those induced by B cells from the uninfected groups, whereas no effect on the (elevated) level of CD25 hi FoxP3 hi T cells was observed ( Figure 4D and Supplementary Figure 3A and 3B) . Indeed, B-cell expression of IL-10 was also reduced to levels found in uninfected donors following CD1d depletion ( Figure 4D and Figure 4 . Induction of interleukin-10 (IL-10) + T cells and FoxP3 + regulatory T cells (Tregs) by B cells from Schistosoma haematobium-infected individuals from a S. haematobium-endemic area (S.h+), uninfected individuals from a S. haematobium-endemic area (S.h−), and uninfected individuals from a S. haematobium-nonendemic area (S.h−). Isolated B cells were cultured at a ratio of 1:1 with allogenic CD4 + CD25 − T cells (from 1 European donor) in the presence of soluble anti-CD3 (1 µg/mL) for 6 days. After coculturing, the cells were restimulated with 100 μg/mL PMA and 1 μg/mL ionomycin for 6 hours; stimulation occurred in the presence of 10 μg/mL brefeldin A for the last 4 hours. Cells were then fixed with FoxP3 fixation buffer (eBioscience). 
DISCUSSION
In this study, we demonstrated that a greater percentage of B cells from schistosome-infected individuals produce IL-10 and/or LAP/TGF-β1, compared with B cells from uninfected individuals. In coculture with CD4 + T cells, these B cells reduced the production of effector T-cell cytokines and more FoxP3 + and IL-10 + T cells were found, compared with cultures from uninfected controls. It is suggested that IL-10-producing Bregs detected following in vitro stimulations may not only be derived from existing circulating IL-10-producing Bregs but may also be derived from progenitor Bregs [25, 33] . Indeed, it was demonstrated that these progenitor cells can develop into IL-10-competent Bregs during a 2-day in vitro stimulation by CD40 ligand and/or BCR ligation [34] . Earlier studies exploring Breg frequencies have not investigated the presence of existing IL-10-competent Bregs, as IL-10 production was only studied following long-term in vitro stimulation, which does not permit discrimination between these 2 B-cell populations [20, 27] . Here, we specifically focused on the presence of already competent IL-10 Bregs and found that a greater percentage of peripheral blood B cells from schistosome-infected individuals could readily produce cytoplasmic IL-10, without long-term in vitro priming or maturation of B cells. Presumably, these processes already occurred in vivo, indicating that schistosome infections indeed prime for the development of readily active IL-10-producing Bregs in humans.
Several studies demonstrated that Bregs may simultaneously produce various regulatory cytokines, such as IL-10 and TGF-β. For example, LPS induced both IL-10 and TGF-β secretion in B cells, and these LPS-activated B cells suppressed the development of diabetes by promoting apoptosis of effector T cells. However, the responsible cytokine was not addressed in this study [18] . Furthermore, in food-allergic mice, allergen-specific T-cell proliferation was suppressed by activated CD5 + B cells secreting both TGF-β and IL-10 [35] . Interestingly, similar IL-10-and TGF-β-producing CD5 + B cells were found in healthy individuals upon milk antigen stimulation [7, 36] . Last, coexpression of IL-10 and TGF-β was also demonstrated in human CD25
hi CD1d hi CD27 hi B cells [37] . However, other studies have suggested that IL-10 and TGF-β are not always expressed by the same Breg subset. For example, CD5 + B cells from mice chronically exposed to ovalbumin and tolerant for allergic airway inflammation predominantly expressed IL-10, while TGF-β expression was not restricted to CD5 + B cells only [8] . This is in agreement with the data presented here, as we also observed that IL-10 and LAP/TGF-β1 were expressed by different Breg subsets: the infected group had a greater percentage of CD24 hi CD27 + B cells expressing LAP/TGF-β1
and a greater percentage of CD1d hi B cells producing IL-10, compared with the uninfected groups. This may suggest that helminth infections can promote the activity of 2 different B-cell subsets. Enhanced Treg activity is one of the hallmarks of chronic Schistosoma infection [38] . Because part of schistosomeinduced Breg activity in mice is centered on their capacity to induce Tregs and modulate T-cell cytokines, we focused on these aspects here. However, during a natural infection it is also possible that other cells, such as antigen-presenting cells, may also be influenced by Bregs [25, 39] We previously reported that 6 months after helminth treatment, B cells still showed increased IL-10 secretion upon in vitro stimulation with soluble egg antigens (SEA), suggesting the presence of a persistent pool of schistosome-specific memory B cells after clearance of infection [20] . Our S. haematobium-uninfected donors are from a schistosome-endemic area, and former infections are likely to have occurred, which may have promoted Breg activity in these individuals at an earlier stage. Indeed, a greater percentage of B cells from the endemic uninfected group express more IL-10 and TGF-β, compared with those from uninfected individuals from a close-by nonendemic area. In addition, this may explain the similar levels of effector T-cell cytokines found in cocultures by B cells from schistosomeinfected and uninfected individuals from the same area. Interestingly, the Treg-inducing and IL-10 + T-cell-inducing capacity was not enhanced in B cells from the endemic uninfected group, indicating that some of the activities or some of the Breg subsets are longer lasting after infection, while others may diminish with time.
Several mouse models showed that parasite products from either Leishmania major or Brugia malayi and the milk glycan LNFPII, containing LeX motifs similar to several schistosome glycoconjugates, can enhance B-cell-derived IL-10 via Toll-like receptor 4 ligation (41, 42) . Furthermore, in vitro stimulation of splenocytes by live schistosome worms induced IL-10-producing B cells, which dampened allergic airway inflammation upon transfer [19] . Last, B cells from helminthinfected patients with multiple sclerosis stimulated with SEA resulted in Toll-like receptor 2-mediated IL-10 production [43] . These findings suggest that the development of Bregs, as observed in schistosome-infected individuals, may be specifically related to the presence and activity of certain helminthderived molecules. However, we cannot exclude that Breg development may also occur as a bystander process resulting from continuous chronic infection in which the immune system desperately tries to counterbalance the inflammation induced by the continuous presence of helminths. Indeed, also other chronic infections with viral or bacterial agents show enhanced IL-10-producing B cells [22, 24, 26] . However, what is interesting and what may point to a helminth-specific Breg population is that the affected Breg subsets in those studies were not characterized by CD1d hi , suggesting that this population is mostly restricted to helminth infections [20, 27] . Reports on patients with autoimmune disease [23, 44, 45] or allergy [7, 36] have shown impairments in Breg frequencies or function, suggesting a role for Bregs in the maintenance of peripheral tolerance in healthy individuals. Therapies aiming to enhance Breg numbers or activity may have potential for future treatment of inflammatory diseases. Interestingly, upregulation of Breg activity was observed in patients with bee venom allergy following successful allergen-specific immunotherapy, reaching levels similar to those found in tolerant beekeepers [46] . As we here observed that schistosome-induced Bregs can affect T-cell responses (ie, reduced effector T-cell cytokines and more Treg induction), applying helminth-derived molecules may form an interesting novel therapy for hyperinflammatory disorders by driving potent Bregs.
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